Explore our review on the increasing burden, deepening inequality and effective prevention initiatives.
Amy C. Moore, Director of Patient Engagement and Advocacy at Summit Therapeutics, Inc., shared a post by Lung Cancer Europe on LinkedIn, adding: “I am not that surprised by this … Read More
Mar 14, 2026
International Society of Geriatric Oncology (SIOG) shared a post on LinkedIn: “Applications for the SIOG Research Masterclass are now closed. Thank you to everyone who applied, shared the opportunity with colleagues, and helped … Read More
Mar 14, 2026
Daniel Stover, Associate Professor of Medicine and the Director of Translational Breast Cancer Research at the Ohio State University Comprehensive Cancer Center, shared a post on LinkedIn: “In breast cancer, -We have … Read More
Mar 14, 2026
Olubukola Ayodele, Breast Cancer Lead at University Hospitals of Leicester NHS Trust, shared a post on LinkedIn: “As an oncologist, I’ve seen firsthand that treating cancer is more than just systemic … Read More
Mar 14, 2026
Miguel Gonzalez Velez, Medical Oncologist at John Theurer Cancer Center, Hackensack University Medical Center, shared a post on X: “Anyone in the US regularly uses CEA as indirect response marker or … Read More
Mar 14, 2026
Herbert Loong, Clinical Associate Professor at The Chinese University of Hong Kong, and Steering Committee Member at Lung Cancer Policy Network, shared a post on X: “Kicking off this year’s … Read More
Mar 14, 2026
Oscar Tahuahua, Medical Oncology Fellow at the National Cancer Institute of Mexico, shared a post on X: “1 in 5 patients. No symptoms. In a prospective study (n=112) of HER2+ and … Read More
Mar 14, 2026
Nieves Martinez Lago, Specialist in the Field (FEA) of Medical Oncology at University Hospital Complex of Santiago de Compostela, shared a post on X: “Cancer risk post solid organ Tx Cohort … Read More
Mar 14, 2026
Cathy Eng, VICC Associate Director of Strategic Relations and Research Partnerships at Vanderbilt-Ingram Cancer, shared a post on LinkedIn: “Spring is here! Please join me and my co-chair Yelena Janjigian … Read More
Mar 14, 2026
Joshua Brody, Associate Professor, Division of Hematology and Oncology at Icahn School of Medicine at Mount Sinai, shared on LinkedIn: “Impressive study – adding bispecific Ab immunotherapy to chemo yields amazing … Read More
Mar 14, 2026